These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 33607819)

  • 21. An open auscultation dataset for machine learning-based respiratory diagnosis studies.
    Zhou G; Liu C; Li X; Liang S; Wang R; Huang X
    JASA Express Lett; 2024 May; 4(5):. PubMed ID: 38717466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Occupational interstitial lung diseases].
    Hofmann-Preiß K
    Radiologie (Heidelb); 2024 Jul; ():. PubMed ID: 39012478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Interstitial Abnormality Progression: Association with Acute Respiratory Events and Implications for Clinical Practice.
    Little BP
    Radiology; 2024 Apr; 311(1):e240791. PubMed ID: 38687214
    [No Abstract]   [Full Text] [Related]  

  • 24. Transformer-Based Network for Accurate Classification of Lung Auscultation Sounds.
    Sonali CS; Kiran J; Chinmayi BS; Suma KV; Easa M
    Crit Rev Biomed Eng; 2023; 51(6):1-16. PubMed ID: 37824331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung Quantitative Ultrasound to Stage and Monitor Interstitial Lung Diseases.
    Dashti A; Roshankhah R; Lye T; Blackwell J; Montgomery S; Egan T; Mamou J; Muller M
    Res Sq; 2024 Apr; ():. PubMed ID: 38645075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Machine-Learning Algorithm to Improve Cohort Identification in Interstitial Lung Disease.
    Farrand E; Gologorskaya O; Mills H; Radhakrishnan L; Collard HR; Butte AJ
    Am J Respir Crit Care Med; 2023 May; 207(10):1398-1401. PubMed ID: 36943196
    [No Abstract]   [Full Text] [Related]  

  • 27. Childhood interstitial lung diseases: current understanding of the classification and imaging findings.
    Tsujioka Y; Nishimura G; Nishi E; Kono T; Nozaki T; Hashimoto M; Yamada Y; Jinzaki M
    Jpn J Radiol; 2024 Jul; ():. PubMed ID: 39012450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A conundrum of honeycombing: challenges in tumor size estimation in patients with honeycombing in the lung.
    Vahidy S; Pereira R; Martins-Filho SN; Kalluri M
    J Thorac Dis; 2024 May; 16(5):2709-2712. PubMed ID: 38883614
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations.
    Copeland CR; Collins BF; Salisbury ML
    Chest; 2021 Jul; 160(1):219-230. PubMed ID: 33609518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF.
    Bonella F; Campo I; Zorzetto M; Boerner E; Ohshimo S; Theegarten D; Taube C; Costabel U
    Orphanet J Rare Dis; 2021 Feb; 16(1):111. PubMed ID: 33639995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis.
    Shi L; Han Q; Hong Y; Li W; Gong G; Cui J; Mao M; Liang X; Hu B; Li X; Luo Q; Zhang Y
    Stem Cell Res Ther; 2021 Feb; 12(1):147. PubMed ID: 33632305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular safety of the tyrosine kinase inhibitor nintedanib.
    Ameri P; Tini G; Spallarossa P; Mercurio V; Tocchetti CG; Porto I
    Br J Clin Pharmacol; 2021 Oct; 87(10):3690-3698. PubMed ID: 33620103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expectations about treatment of idiopathic pulmonary fibrosis: Comparative survey of patients, carers and physicians (the RESPIR French survey).
    Cottin V; Bergot E; Bourdin A; Nunes H; Prévot G; Wallaert B; Marchand-Adam S
    Respir Med Res; 2021 May; 79():100811. PubMed ID: 33618076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study.
    Liang J; Cao H; Yang Y; Ke Y; Yu Y; Sun C; Yue L; Lin J
    Front Med (Lausanne); 2021; 8():626953. PubMed ID: 33614683
    [No Abstract]   [Full Text] [Related]  

  • 35. Gemcitabine maintenance therapy after gemcitabine and platinum drug chemotherapy for naive stage IIIB/IV squamous cell lung cancer: a phase II study.
    Hamai K; Fujitaka K; Kitaguchi S; Tamamoto S; Takao S; Nishida A; Furutama J; Horimasu Y; Masuda T; Miyamoto S; Awaya Y; Kondo T; Shoda H; Ishikawa N; Yamasaki M; Hattori N
    Anticancer Drugs; 2021 Aug; 32(7):767-772. PubMed ID: 33967202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
    Behr J; Prasse A; Kreuter M; Johow J; Rabe KF; Bonella F; Bonnet R; Grohe C; Held M; Wilkens H; Hammerl P; Koschel D; Blaas S; Wirtz H; Ficker JH; Neumeister W; Schönfeld N; Claussen M; Kneidinger N; Frankenberger M; Hummler S; Kahn N; Tello S; Freise J; Welte T; Neuser P; Günther A;
    Lancet Respir Med; 2021 May; 9(5):476-486. PubMed ID: 33798455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targets in lung tissue remodelling and fibrosis.
    Liu G; Philp AM; Corte T; Travis MA; Schilter H; Hansbro NG; Burns CJ; Eapen MS; Sohal SS; Burgess JK; Hansbro PM
    Pharmacol Ther; 2021 Sep; 225():107839. PubMed ID: 33774068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Idiopathic pulmonary fibrosis : from biomarkers to new therapeutic areas].
    Guiot J; Henket M; Njock MS; Moermans C; Struman I; Corhay JL; Louis R
    Rev Med Liege; 2021 Mar; 76(3):166-172. PubMed ID: 33682385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The burden of progressive fibrotic interstitial lung disease across the UK.
    Simpson T; Barratt SL; Beirne P; Chaudhuri N; Crawshaw A; Crowley LE; Fletcher S; Gibbons MA; Hallchurch P; Horgan L; Jakaityte I; Lewis T; McLellan T; Myall KJ; Miller R; Smith DJF; Stanel S; Thillai M; Thompson F; Wallis T; Wu Z; Molyneaux PL; West AG
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33678609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Autoimmunity to Peptides of Collagen V α1 Chain as Newly Biomarkers of Early Stage of Systemic Sclerosis.
    Velosa APP; Brito L; de Jesus Queiroz ZA; Carrasco S; Tomaz de Miranda J; Farhat C; Goldenstein-Schainberg C; Parra ER; de Andrade DCO; Silva PL; Capelozzi VL; Teodoro WR
    Front Immunol; 2020; 11():604602. PubMed ID: 33643291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.